Claire Thomas
Direktor/Vorstandsmitglied bei REBUS HOLDINGS, INC.
Vermögen: - $ am 31.12.2023
Aktive Positionen von Claire Thomas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REBUS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 12.10.2016 | - |
Independent Dir/Board Member | 12.10.2016 | - | |
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Claire Thomas
Ehemalige bekannte Positionen von Claire Thomas
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASTELLAS PHARMA INC. | Corporate Officer/Principal | 31.07.2013 | 30.06.2016 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.08.2008 | 01.01.2013 |
Ausbildung von Claire Thomas
University of Illinois | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Japan | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ASTELLAS PHARMA INC. | Health Technology |
REBUS HOLDINGS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Agensys, Inc.
Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Claire Thomas
- Erfahrung